Clinical Trial Update: SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating HPV16 circulating DNA as a biomarker for detecting recurrence and improving post-therapy surveillance in HPV16-driven oroph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: UNICANCER | Conditions: Oropharynx Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING